Global Allergic Rhinitis Market; by Type (Seasonal, Perennial and Non allergic rhinitis), by Treatment (Antihistamines, Decongestants, Eye drops, Nasal sprays and others) and by Test (Skin Test, IgE RAST Test and Complete Blood Count) – Forecast to 2023
Hay fever is another name for allergic rhinitis which is a nose related disease. This fever affects nose first and clogs it. The cause of this is due to allergens to which the affected person is highly exposed to. Other parts of the body affected due to hay fever includes ears, eye and throat and they are mostly affected due to blocked nose. There are various products available to treat problems arising due to allergic rhinitis. Every second a person is affected by cold and cough. Medicines available to treat allergic rhinitis are available in almost every chemist shop. The sale for anti-allergic rhinitis are increasing and is expected to increase further in future as well.
Global Allergic Rhinitis market Players:
There are various players in the allergic rhinitis market; some of them are Merck (US), GSK (UK), Sanofi (France), Cigna (USA), Himalaya (India), J&J (US), Chong kun Dang Pharmaceutical Corp. (South Korea), Faes, Farma (Spain), Glenmark Pharmaceutical (India), Hisamitsu Pharmaceutical Co.in (Japan), Ampio pharmaceutical Inc. (US), Olain Farm (Lavtvia), and others.
Taste the market data and market information presented in more than 50 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Global Allergic Rhinitis Market” Research Report – Forecast till 2023.
Sample Report Available at https://www.marketresearchfuture.com/sample_request/1547 .
GSK, has announced a new spray intranasal steroid fluticasone furoate for the treatment of allergic rhinitis in Philippines. Bureau of Food and Drugs, has approved nasal spray for the treatment of seasonal allergic rhinitis and perennial allergic rhinitis in adults and children with minimum age of two years. In 2014 company got FDA approval to launch Flonase, to be sold over the counter. This drug is used to treat temporary hay fever.
Johnson & Johnson, the company has a wide range of products which also includes medical products. The company recently has announced the launch of allergy spray named Rhinocort that is available over the counter. The Rhinocort will be sold over the counter all over America. The company is also the maker of a very well know product the Zyrtec.
Merck as well as the maker of various products for seasonal, perennial allergic rhinitis. Merck is collaborating with F-star to strengthen its immune-oncology portfolio. The F-star is a bio-pharmaceutical company in UK.
Another big brands that have a huge product variety for the allergic symptoms is The Himalayas Drug Company which is an Indian brand and has herbal products for various diseases. There are various players in US, Japan and China who are operating in the global allergic rhinitis market.
The market of allergic rhinitis is segmented into types by treatment and by test. The types of allergic rhinitis includes seasonal, perennial and non-allergic rhinitis. On the basis of treatment the market is segmented into antihistamines, decongestants, eye drops, nasal sprays, immunotherapy, sublingual immunotherapy (SLIT), and home remedies. The antihistamine segment is further sub-segmented into drugs like Allegra, Clarinex, Xyzal and Zyrtec. The decongestants segment is also sub-segmented into afrin nasal spray, sudafed, sudafed PE and zyrtec-D. On the basis of test the segmentation is done into skin tests, IgE RAST test, and complete blood count.
Browse complete report at https://www.marketresearchfuture.com/reports/allergic-rhinitis-market .
The common name for allergic rhinitis is hay fever. It is diagnosed when symptoms appear which includes itchy nose, mouth, eyes, throat, skin, as well as other parts of the body; along with this other symptoms includes running nose, sneezing, watery eyes, problem during smelling, cough and sore throat. The causes of allergic rhinitis are allergens which includes pollen, mould, animal dander, and dust. The body releases chemicals that cause allergy symptoms. Hay fever and allergies is an inherited disease and if parents have their offspring will most likely inherit it. The chance increases if mother has allergies. The allergy or hay fever can be avoided by preventing one from coming in contact with allergen. Also some preventive measure like washing the bed sheets and blankets regularly must be followed along with using clean handkerchief and clothes. Some people are also allergic to soaps and some food which can cause allergic rhinitis. They can use alternate product which will not cause them allergic rhinitis. The market of anti-allergic products is growing. The trend of using nasal sprays and inhalers is increasing since these products are easy to use, they are handy and provides quick relief. The market of allergic rhinitis will grow at the CAGR of 7% during the forecasted period of 2017 to 2023. The market is likely to achieve $ 15 billion by 2023.
Table Of Contents
1 Report Prologue
2 Market Introduction
2.2 Scope Of Study
2.3 Research Objective
2.4 Assumptions & Limitations
Company Name: Market Research Future
Contact Person: Akash Anand
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –